CIK 0001604821 · Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010894487
- Phone
- 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-28 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −200 | $192.20 | $38K | 65,993 |
| 2025-10-28 | Sheena Jonathan Director | Sale 10b5-1 | −191 | $191.46 | $37K | 235,730 |
| 2025-10-27 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Sale 10b5-1 | −781 | $192.32 | $150K | 151,627 |
| 2025-10-27 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −1,008 | $192.32 | $194K | 116,259 |
| 2025-10-27 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −935 | $192.32 | $180K | 202,757 |
| 2025-10-27 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −2,335 | $192.32 | $449K | 153,520 |
| 2025-10-27 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −781 | $192.32 | $150K | 68,408 |
| 2025-10-27 | Sheena Jonathan Director | Sale 10b5-1 | −288 | $192.32 | $55K | 235,921 |
| 2025-10-24 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −755 | $196.77 | $149K | 69,189 |
| 2025-10-23 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −495 | $187.16 | $93K | 69,944 |
| 2025-10-22 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −920 | $186.68 | $172K | 69,189 |
| 2025-10-22 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +1,250 | 70,439 | ||
| 2025-10-22 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Unit 10b5-1 | −1,250 | 0 | ||
| 2025-10-21 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Sale 10b5-1 | −339 | $187.95 | $64K | 152,408 |
| 2025-10-21 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −292 | $187.95 | $55K | 117,267 |
| 2025-10-21 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −464 | $187.95 | $87K | 203,692 |
| 2025-10-21 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −1,603 | $187.95 | $301K | 155,855 |
| 2025-10-21 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −602 | $187.95 | $113K | 70,109 |
| 2025-10-21 | Sheena Jonathan Director | Sale 10b5-1 | −93 | $187.95 | $17K | 236,209 |
| 2025-10-20 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Option exercise 10b5-1 | +856 | 204,156 |
Page 36 of 39 · 767 trades